Global, regional, & national burden of rheumatic heart disease, 1990-2015

New England Journal of Medicine

Volumn 377, Issue 8, 2017, Pages 713-722

  Watkins, David A ^a,c   Johnson, Catherine O ^b   Colquhoun, Samantha M ^d   Karthikeyan, Ganesan ^f   Beaton, Andrea ^g   Bukhman, Gene ^h,i   Forouzanfar, Mohammed H ^b   Longenecker, Christopher T ^j   Mayosi, Bongani M ^c   Mensah, George A ^k   Nascimento, Bruno R ^l   Ribeiro, Antonio L P ^l   Sable, Craig A ^g   Steer, Andrew C ^d   Naghavi, Mohsen ^b   Mokdad, Ali H ^b   Murray, Christopher J L ^b   Vos, Theo ^b   Carapetis, Jonathan R ^e   Roth, Gregory A ^a,b  

^a UNIVERSITY OF WASHINGTON SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF WASHINGTON   (United States)

^c UNIVERSITY OF CAPE TOWN   (South Africa)

^d UNIVERSITY OF MELBOURNE   (Australia)

^e PRINCESS MARGARET HOSPITAL FOR CHILDREN   (Australia)

^f ALL INDIA INSTITUTE OF MEDICAL SCIENCES   (India)

^g CHILDREN'S NATIONAL MEDICAL CENTER   (United States)

^h HARVARD MEDICAL SCHOOL   (United States)

ⁱ BRIGHAM AND WOMEN S HOSPITAL   (United States)

^j CASE WESTERN RESERVE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^k NATIONAL HEART LUNG AND BLOOD INSTITUTE   (United States)

^l FEDERAL UNIVERSITY OF MINAS GERAIS   (Brazil)

more..

Author keywords

[No Author keywords available]

Indexed keywords

AFRICA SOUTH OF THE SAHARA; AGE; CARDIOVASCULAR MORTALITY; CAUSE OF DEATH; DISEASE ASSOCIATION; HEART FAILURE; HUMAN; PACIFIC ISLANDS; PREVALENCE; PRIORITY JOURNAL; REVIEW; RHEUMATIC HEART DISEASE; SOUTH ASIA; SYSTEMATIC REVIEW; TREND STUDY; COST OF ILLNESS; DEVELOPING COUNTRY; ENDEMIC DISEASE; GLOBAL HEALTH; MORTALITY; QUALITY ADJUSTED LIFE YEAR; STATISTICS AND NUMERICAL DATA; TRENDS;

COST OF ILLNESS; DEVELOPING COUNTRIES; ENDEMIC DISEASES; GLOBAL HEALTH; HUMANS; MORTALITY; PREVALENCE; QUALITY-ADJUSTED LIFE YEARS; RHEUMATIC HEART DISEASE;

EID: 85028308771     PISSN: 00284793     EISSN: 15334406     Source Type: Journal    
DOI: 10.1056/NEJMoa1603693     Document Type: Review

References (31)

1. Marijon E, Mirabel M, Celermajer DS, Jouven X. Rheumatic heart disease. Lancet 2012; 379: 953-64.
2. Meira ZM, Goulart EM, Colosimo EA, Mota CC. Long term follow up of rheumatic fever and predictors of severe rheumatic valvar disease in Brazilian children and adolescents. Heart 2005; 91: 1019-22.
3. Longo-Mbenza B, Bayekula M, Ngiyulu R, et al. Survey of rheumatic heart disease in school children of Kinshasa town. Int J Cardiol 1998; 63: 287-94.
4. Gordis L. The virtual disappearance of rheumatic fever in the United States: lessons in the rise and fall of disease - T. Duckett Jones Memorial Lecture. Circulation 1985; 72: 1155-62.
5. Massell BF, Chute CG, Walker AM, Kurland GS. Penicillin and the marked decrease in morbidity and mortality from rheumatic fever in the United States. N Engl J Med 1988; 318: 280-6.
6. Doukky R, Abusin SA, Bayissa YA, Kelly RF, Ansari AH. Rheumatic heart disease in modern urban America: A cohort study of immigrant and indigenous patients in Chicago. Int J Cardiol 2014; 175: 178-80.
7. Rothenbühler M, O'Sullivan CJ, Stortecky S, et al. Active surveillance for rheumatic heart disease in endemic regions: A systematic review and meta-Analysis of prevalence among children and adolescents. Lancet Glob Health 2014; 2(12): E717-e726.
8. Rheumatic diseases: first report of the Expert Committee. WHO technical report series no. 78. Geneva: World Health Organization, 1954.
9. Bach JF, Chalons S, Forier E, et al. 10- Year educational programme aimed at rheumatic fever in two French Caribbean islands. Lancet 1996; 347: 644-8.
10. Nordet P, Lopez R, Dueñas A, Sarmiento L. Prevention and control of rheumatic fever and rheumatic heart disease: The Cuban experience (1986-1996- 2002). Cardiovasc J Afr 2008; 19: 135-40.
11. Günther G, Asmera J, Parry E. Death from rheumatic heart disease in rural Ethiopia. Lancet 2006; 367: 391.
12. Colquhoun SM, Condon JR, Steer AC, Li SQ, Guthridge S, Carapetis JR. Disparity in mortality from rheumatic heart disease in indigenous Australians. J Am Heart Assoc 2015; 4(7): E001282.
13. Parks T, Kado J, Miller AE, et al. Rheumatic heart disease-Attributable mor-Tality at ages 5-69 years in Fiji: A five-year, national, population-based record-linkage cohort study. PLoS Negl Trop Dis 2015; 9(9): E0004033.
14. Maurice J. Rheumatic heart disease back in the limelight. Lancet 2013; 382: 1085-6.
15. Marijon E, Ou P, Celermajer DS, et al. Prevalence of rheumatic heart disease detected by echocardiographic screening. N Engl J Med 2007; 357: 470-6.
16. Global action plan for the prevention and control of noncommunicable diseases 2013-2020. Geneva: World Health Organization, 2013.
17. Remenyi B, Carapetis J, Wyber R, Taubert K, Mayosi BM. Position statement of the World Heart Federation on the prevention and control of rheumatic heart disease. Nat Rev Cardiol 2013; 10: 284-92.
18. GBD 2015 DALYs and HALE Collaborators. Global, regional, and national disability-Adjusted life years (DALYs) for 315 diseases and injuries and healthy life expectancy (HALE) for 195 countries and territories, 1990-2015: A systematic analysis for the Global Burden of Diseases, Injuries, and Risk Factors (GBD) 2015 Study. Lancet 2016; 388: 1603-58.
19. GBD 2015 Disease and Injury Incidence and Prevalence Collaborators. Global, regional, and national incidence, prevalence, and years lived with disability for 310 acute and chronic diseases and injuries, 1990-2015: A systematic analysis for the Global Burden of Disease Study 2015. Lancet 2016; 388: 1545-602.
20. GBD 2015 Mortality and Causes of Death Collaborators. Global, regional, and national life expectancy, all-cause and cause-specific mortality for 249 causes of death, 1980-2015: A systematic analysis for the Global Burden of Disease Study 2015. Lancet 2016; 388: 1459-544.
21. Rheumatic fever and rheumatic heart disease. Technical report series no. 923. Geneva: World Health Organization, 2004.
22. Reményi B, Wilson N, Steer A, et al. World Heart Federation criteria for echocardiographic diagnosis of rheumatic heart disease -An evidence-based guideline. Nat Rev Cardiol 2012; 9: 297-309.
23. Barendregt JJ, Van Oortmarssen GJ, Vos T, Murray CJ. A generic model for the assessment of disease epidemiology: The computational basis of DisMod II. Popul Health Metr 2003; 1: 4.
24. Social determinants of health visualization. Seattle: Institute for Health Metrics and Evaluation, 2015 http://vizhub.healthdata.org/sdh).
25. Wyber R, Zühlke L, Carapetis J. The case for global investment in rheumatic heart-disease control. Bull World Health Organ 2014; 92: 768-70.
26. Zühlke L, Engel ME, Karthikeyan G, et al. Characteristics, complications, and gaps in evidence-based interventions in rheumatic heart disease: The Global Rheumatic Heart Disease Registry (the REMEDY study). Eur Heart J 2015; 36: 1115-1122.
27. Beaton A, Okello E, Aliku T, et al. Latent rheumatic heart disease: outcomes 2 years after echocardiographic detection. Pediatr Cardiol 2014; 35: 1259-67.
28. Zühlke L, Engel ME, Lemmer CE, et al. The natural history of latent rheumatic heart disease in a 5 year follow-up study: A prospective observational study. BMC Cardiovasc Disord 2016; 16: 46.
29. Zühlke L, Mayosi BM. Echocardiographic screening for subclinical rheumatic heart disease remains a research tool pending studies of impact on prognosis. Curr Cardiol Rep 2013; 15: 343.
30. Roberts K, Maguire G, Brown A, et al. Echocardiographic screening for rheumatic heart disease in high and low risk Australian children. Circulation 2014; 129: 1953-61.
31. Nascimento BR, Beaton AZ, Nunes MC, et al. Echocardiographic prevalence of rheumatic heart disease in Brazilian schoolchildren: data from the PROVAR study. Int J Cardiol 2016; 219: 439-45.